A note before you read this: This reflects my personal experience and the stock’s fundamentals as of February 2021 — genuinely old given how quickly markets move. It isn’t current investment advice. Check today’s price, financials, and recent news before making any decision, and consider speaking with a SEBI-registered financial advisor for personalized guidance.
Being an amateur stock trader means you get to learn every day, so after my stint with the stock market and share trading, I see that I follow a particular stock based on people’s advice and study about it. So Wockhardt Ltd was something which I been following recently.
This company deals with the pharmaceutical industry providing formulations, vaccines, and pharmaceuticals ingredients. They have a global presence with manufacturing facilities in the Asia Pacific and MENA regions. Wockhardt Ltd also has other subsidiaries like hospitals and schools.
At first, I thought it is an international company which has an Indian branch. But a quick look on the internet made me realize it is an Indian company with an international name. It was found by Dr. Habil Khorakiwala in the 1960s in Mumbai.
Wockhardt Ltd was, at the time of writing, an unpredictable stock — you could see price variation with regular intervals, buying when it was low and selling when it was high, with these swings happening over fairly short intervals.

At the time, the promoter was holding more than 70%, which was a good sign. EPS and Industry PE value were also in a good range. It was a dividend-paying company till 2016, after that I didn’t see updated data. I could see the company’s cash flow kept increasing from operations, which suggested good business — possibly related to COVID-19 vaccine manufacturing at the time.
Since it had low and high trends at the time, suggesting a target price was difficult — you’d have needed to follow the chart and get an average price. This reflects my own approach and risk tolerance at the time, not a recommendation for anyone else’s strategy.
Disclaimer: As an amateur stock trader I wrote this as my personal experience in the share market at the time — please read it for information rather than as a strong recommendation, and always verify current data before acting.